The Valley Desk

ArticleCurrent medical research and opinionPublished

Real-world treatment patterns and outcomes of patients treated with commercial chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Current medical research and opinion
Published
Subject terms
Humans; Multiple Myeloma; Recurrence; Treatment Outcome; Immunotherapy, Adoptive; Retrospective Studies; Adult; Aged; Middle Aged; Female; Male; Practice Patterns, Physicians'
PubMed ID
42642985
Added to directory
Source checked

Report a correction or request removal